Q2 EPS Estimate for PDS Biotechnology Decreased by Analyst
PDS Biotechnology Co. (NASDAQ:PDSB – Free Report) – Stock analysts at HC Wainwright decreased their Q2 2025 earnings estimates for PDS Biotechnology in a research report issued to clients and investors on Wednesday, June 11th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of ($0.25) for the quarter, […]
